[Evaluation of prognostic nutritional index (PNI) as a prognostic indicator in multimodal treatment for gynecological cancer patients].
We assessed the usefulness of PNI (PNI = 10 x serum albumin + 0.005 x peripheral lymphocytes) as a prognostic indicator and determinant of multimodal treatment for 30 gynecological patients (control group: 12 patients with gynecological benign disease; good prognostic group: 10 with more than two-year survival having gynecological cancer; poor prognostic group: 8 with less than one-year survival having gynecological cancer). It was concluded that 1) PNI of the poor prognostic group was significantly lower than that of good prognostic group and control group (p < 0.01); 2) PNI is effective as a prognostic indicator; and 3) PNI is useful in clinical practice as a determinant of the multimodal treatment and high risk group.
Takushima
Y
Y
Section of Obstetrics and Gynecology, Syuto General Hospital.
Abe
H
H
Yamashita
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D008875:Middle Aged; D015596:Nutrition Assessment; D010051:Ovarian Neoplasms / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D015996:Survival Rate; D014594:Uterine Neoplasms / Q000401:mortality / Q000628:therapy*
D005047:Etoposide; D002945:Cisplatin